Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on 60 mg ER Torsemide Bioavailability
NCT03215875Phase 1Completed
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of torasemide in heart failure (HF) and edema (2 arms). Primary endpoints: Peak torsemide plasma concentration at 36 hours and Total torsemide plasma concentration at 36 hours. Started Oct 2017; status: completed.
02
Drugs
torasemide
03
Conditions
heart failure (HF)edema
Beyond the preview
Go deeper on NCT03215875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215875.